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A valuable approach to the characterization of known and novel autoantigens
has used cell component-reactive monoclonal antibodies (mAb) derived from
immortalized, in vivo-primed, autoreactive B lymphocytes . For example, in
animal systems, murine mAb have been produced from spleen cells of autoim-
mune inbred mouse strains and used to characterize the autoantigenic structures
of Sm (1, 2) and nRNP (3, 4), as well as DNA (5-12) and RNA (13) . Similarly,
human mAb derived from patients with autoimmune disorders have provided
valuable insights into the autoantigenic determinants of the DNA molecule,
demonstrating unique and crossreactive features (14-17) . However, although
there have been human mAb generated that are reactive with non-DNA autoan-
tigenic moieties (15, 18), progress in this area has been considerably slower .
This report describes an autoantibody-producing B cell clone, immortalized
from a patient with systemic lupus erythematosus (SLE), that secretes an IgM
mAb reactive with DNA and a salt-extractable autoantigen found primarily in
the nucleolus. This antigen is no longerbound by the mAb after in situ treatment
of the cells with either RNase or trypsin, binds avidly to DEAF-cellulose, and
appears to consist of at least two polypeptide chains, of 17 and 18 kD . The
following studies suggest that the antigen probably is not related to conventional
RNA-associated autoantigens and may represent a novel system . A portion of
these studies has been presented previously (19) .
Materials and Methods
Isolation and Activation ofDonor Peripheral Blood Mononuclear Cells (PBMC)
Sterile, heparinized venous blood was obtained from a patient (DW) with active,
untreated systemic lupus erythematosus (SLE) followed at The Rockefeller University
Hospital . This blood was separated intoPBMC by centrifugation on a Ficoll-Paque cushion
(p 1 .077 ; Pharmacia Fine Chemicals, Piscataway, NJ) . PBMC were divided further into T
and non-T cell fractions by the neuraminidase-treated sheep erythrocyte rosetting tech-
nique (20) . Non-T cells were cultured at a concentration of 2 x 106 cells/ml for 3.5 d in
the presence of fixed Staphylococcus aureus, Cowan strain I (0.01% final concentration ;
Calbiochem-Behring Co ., San Diego, CA) . Before hybridization, viable cells were isolated
by another Ficoll-Paque gradient centrifugation step,
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Lymphoid cells were cultured in RPMI 1640 medium supplemented with 10% FCS
(Reheis Chemical Co ., Phoenix, AZ), glutamine (4 mM), penicillin and streptomycin (100
U/ml), and kanamycin (50 mg/ml) .The hypoxanthine/guanine phosphoribosyl transferase
(HGPRT)'-deficient, EBV-transformed, human B lymphoblastoid cell line, 0467 .3, was
prepared by subcloning GM 0467 (Genetic Mutant Cell Repository, Camden, NJ) as
previously described (21). These cells were cultured at 105 cells/ml in culture medium
containing 8-azaguanine for 5 d before hybridization . The human laryngeal epidermoid
carcinoma cell line, HEp-2 (22), was obtained from the Genetic Mutant Cell Repository
and cultured as recommended .
Generation ofHuman mAb
Human X human B cell hybridomas were constructed by somatic cell hybridization
techniques as previously described (21) . Briefly, mitogen-activated human B lymphoblasts
were fused with the HGPRT-deficient human B cell variant, 0467.3, at a 1 :1 ratio, by
exposure for 2 min at room temperature to 0.5 ml of 40% PEG (^-1,000 mol wt; J . T .
Baker Chemical Co ., Phillipsburg, NJ) followed by centrifugation for 4 min at 1,000 rpm .
After two washes, cells were dispensed into 96-well plates at a density of 5 X 10' parental
tumor cells per microwell in culture medium containing hypoxanthine (10-' M), thymidine
(5 X 10-5 M), and aminopterin (10' M) (HAT) . Cultures were fed with the same medium
approximately every third day for 3 wk and then with medium without aminopterin until
assaying for Ig content and antigen-binding activity .
Enzyme-linkedImmunosorbent Assays (ELISA)
Anti-DNA ELISA. Antibodies to DNA were detected as previously reported (23) .
Briefly, 96-well polystyrene plates (Costar, Cambridge, MA) were exposed to 0.001
salmon protamine sulfate (Sigma Chemical Co ., St . Louis, MO) for 1 h at room tempera-
ture, washed with distilled water, and then reacted for 16 h at 4°C with 150 Ul of calf
thymus DNA (Worthington Biochemical Corp., Freehold, NJ) at 5 kg/ml in PBS . At this
point, plates were washed, blocked with culture medium for I h, and then incubated with
mAb or human sera with known levels of reactivity to DNA for 18 h at 4°C . After
washing three times, affinity-purified, peroxidase-labeled, goat anti-human K+ a antibod-
ies (Tago, Inc., Burlingame, CA) were added for 1 h at 37°C . The assay was developed
for 1 h at 37'C with 4-aminoantipyrene/phenol substrate (24) .
Anti-Extractable Nuclear Antigen (ENA) ELISA .
￿
Antibodies to an assortment of salt-
extractable antigens from rabbit thymus were detected as previously described (25) . The
crude soluble antigenic extract was obtained by 0.15 M NaCI extraction of rabbit thymus
acetone powder (RTE) (Pel Freez Biologicals, Rogers, AR) for 3 h at 4°C ; in certain
experiments, this crude extract was fractionated by NaCI gradient (0.05-0.5 mM) elution
from DEAE-cellulose column (DE52 ; Whatman, Inc ., Clifton, NJ) as described (25).
Fluorescent AntinuclearAntibody (ANA)Assay
Antibodies to cellular antigens were detected by a double sandwich immunofluorescent
antibody technique using human HEp-2 cells as the substrate . After 48 h of growth on
coverslips, HEp-2 cells were treated with cold 100% methanol for 5 min at -20°C, and
then with 0.5% Triton X-100 in PBS for 1 min at room temperature . The fixed,
permeabilized cells were incubated with fresh culture medium for 2 h at room tempera-
ture, washed, and reacted for 18 h with cell culture supernatants containing various
human monoclonal antibodies or with serum containing reference autoantibodies. After
three washes with fresh medium, cells were exposed to 40 jug/ml ofaffinity-purified rabbit
anti-human Ig antibodies for 1 h at room temperature . Subsequently, cells were washed
three times and then reacted with an FITC-labeled goat anti-rabbit antibody preparation
'Abbreviations used in this paper:
￿
ANA, antinuclearantibody ; DRB, 5,6-dichloro-l-,B-ribofuran-
osylbenzimidazole ; dsDNA, double-stranded DNA ; ENA, extractable nuclear antigen; HGPRT,
hypoxanthine/guanine phosphoribosyl transferase ; RTE, rabbit thymus extract ; ssDNA, single-
stranded DNA .1174
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that had been preabsorbed to remove reactivity with cellular constituents (the gift of Dr .
E . Wang ofThe Rockefeller University) .
Antibodies reactive with native DNA were detected by indirect immunofluorescence
using fixed Crithidia luciliae organisms (AnDNA FluoroKit II ; Clinical Sciences Inc .,
Whippany, NJ) according to the directions of the manufacturer .
Rabbit antibodies reactive with mammalian RNA polymerase I were kindly provided
by Dr . Kathleen Rose of The University of Texas Health Science Center at Houston .
Indirect immunofluorescent assays were performed with these antibodies and a rhoda-
mine-conjugated preparation of goat antibodies to rabbit Ig (Tago, Inc .) .
Treatment ofHEp-2 Cells with 5,6-Dichloro-1-,Q-ribofuranosylbenzimidazole (DRB),
Actinomycin D, DNase or RNase, and Trypsin
DRB and actinomycin D were purchased from Calbiochem-Behring Co . For studies
using these compounds, HEp-2 cells were cultured for 48 h at 37 °C in 5% C02 atmosphere
and then incubated with either DRB, at concentrations of 25, 5, or 1 ug/ml for 6 h, or
with actinomycin D, at concentrations of 5.0, 0.5, and 0.05 ug/ml for 2 h . Under the
conditions described, the addition of these compounds did not grossly alter the growth
characteristics or cell viability of the HEp-2 cells. At the end of the incubation periods,
cells were washed, fixed, and then used for the ANA assay .
Deoxyribonuclease I (DNase) and pancreatic ribonuclease A (RNase) were purchased
from Sigma Chemical Co . DNase contaminating the RNase preparation was inactivated
by heating as described (26) . In certain experiments, HEp-2 cells were treated for 30 min
at 22° C with 50 1Al of 50 ug/ml of either DNase or RNase in phosphate-buffered saline
before staining with various antibody preparations (27) .
Immunoprecipitation and SDS-PAGE Analysis of 3'S-labeled Cellular Antigens
The human m eloid cell line, K562, was cultured for 16 h at 37°C at a concentration
of 4 x 106 cells~ml in methionine-deficient RPMI 1640 medium containing 50 pCi of
I3SSJmethionine (-1,100 Ci/mmol ; New England Nuclear, Boston, MA), and 10% dialyzed
FCS . A cell extract was prepared and immunoprecipitations were performed with human
autoimmune sera as described (28) . A modification of this procedure was used for
immunoprecipitations with human mAb-containing supernatants. For immunoprecipita-
tions, 5-10 ml of culture supernatant containing the appropriate mAb or 10 gl of patient
serum was rotated with the extract of 106 cells for 14 h at VC . C . The immune complexes
were reacted for 2 h at 4°C with protein A-Sepharose beads (Pharmacia Fine Chemicals)
that had been coated for 16 h with affinity-purified rabbit anti-human Ig antibodies . The
immunoprecipitates were washed and proteins were eluted by boiling for 5 min in 0.25
M sucrose, 2.5% SDS, 0.1 M Tris, pH 7.5, 5.0mM EDTA, 0.1 M dithiothreitol, 0.005%
bromphenol blue, followed by analysis on 12.5 or 15% SDS-polyacrylamide gels . The gels
were stained with Coomassie blue, destained, and fluorographed as previously described
(29) .
Results
Patient Description .
￿
The cell lines described in this report were derived using
the peripheral blood B lymphocytes of a 15-yr-old black woman followed at The
Rockefeller University Hospital for SLE . The patient had a 3-yr history of
intermittent high fevers, joint pains and swelling, oral ulcers, and occasional mild
proteinuria . Pertinent laboratory data included erythrocyte sedimentation rate
32 mm/h, hemoglobin, 9.1 gm%, white blood cell count, 2,800 with a normal
differential count, total serum protein, 8.6 g/dl, with an elevated serum IgG,
2,600 mg% (nl < 1,800) .
The patient's serum contained ANA at a dilution of 1 :1,280, with bright,
homogeneous immunofluorescent staining of the nucleoli, granular staining ofCHIORAZZI AND REEVES
￿
1175
FIGURE 1 .
￿
Indirect immunofluorescent staining offixed HEp-2 cells using the serum (diluted
1 :20) of patient DW . Original magnification x 400.
the nucleoplasm, and weak cytoplasmic fluorescence (Fig . 1) . Solid-phase enzyme
immunoassay and fluid-phase Farr radioimmunoassay revealed significant serum
antibody binding to heat-denatured (1 :30,000 and 1 :1,000, respectively) and
native (1 :6,000 and 1 :250, respectively) DNA. Antibodies to native DNA were
confirmed in a Crithidia luciliae immunofluorescent assay that showed character-
istic staining of kinetoplasts at a serum dilution of 1 :640 . In addition, antibodies
to the battery of ENA contained in RTE were detected by ELISA (1 :2,500) ;
these antibodies reacted in hemagglutination assay (30) with antigenic sites that
were sensitive to RNase digestion, which were found subsequently to be distinct
from the nRNP determinants . Finally, serum autoantibodies reactive with
Ro/SSA and Ku (p70/p80) antigens also were detected by immunoprecipitation
of radiolabeled cellularRNA or proteins, respectively .
Generation ofHuman B Cell Lines Reactive with Autoantigens .
￿
B lymphocytes
isolated from the peripheral blood of this patient were activated for 4 d by 0.01
formalinized Staphylococcus aureus, Cowanstrain 1 (protein A-positive)organisms
andthen fused, in the presence ofpolyethylene glycol, with the HGPRT-deficient
variant human B cell line 0467.3 . After 3 wk of selection in HAT medium, 97
growth-positive wells were obtained and tested for production ofhuman Ig and
for reactivity with various autoantigens .
Table I lists a series of monoclonal antibodies secreted by certain of these 97
hybridomas and the parental cell line (0467.3) and their reactivities with single-
stranded DNA (ssDNA), double-stranded DNA (dsDNA), and a crude ENA
preparation . 36 of the 97 growth-positive cultures produced human IgM mAb1176
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TABLE I
Reaclivities ofHumanMonoclonal Antibodies with DNA andRabbit
Thymus Extract
Clone
Absorbance at 492nm in ELISA
reactive with either native and/or ssDNA, although reactivity with the latter was
usually more intense. Initially, two cultures, W8 and W99, were found also to
react in ELISA with ENA (Table I). However, after several more weeks of
culture, only the W8 cell line continued to secrete an mAb reactive with both
DNA and ENA. This cell line has now been cultured intermittently for over 3
yr without loss of reactivity. The property of dual DNA and RTE reactivity by
the mAb has not been altered by continued culture or by limiting-dilution
cloning ofthe cell line (data not shown).
The W8 human mAb next was tested for its reactivity with fixed HEp-2 cells
andwith Crithidia luciliae organisms inindirect immunofluorescent assays. Strong
staining of HEp-2 cell nucleoli was demonstrated (Fig. 2A), whereas nucleo-
plasmic immunofluorescence was negligible, and cytoplasmic reactivity minimal.
When present, cytoplasmic staining varied from preparation to preparation and
within certain cells ofan individual fixed-cell preparation. Reactivity with Crith-
idia kinetoplasts wasnot detected, evenafter overnight incubation with the mAb.
Thus, the staining patterns and the ELISA binding data ofthe W8 mAb were
similar to those mentioned above for a portion ofthe polyclonal antibodies from
the original SLE donor's serum, i.e., reactivity with both single-stranded DNA
and an extractable nuclear antigen in solid-phase enzyme immunoassay and with
nucleoli by immunofluorescent assay.
Partial Characterization of the Autoantigen(s) Bound by the W8 mAb.
￿
In an
attempt to define the molecular characteristics of the antigen(s) recognized by
the W8 mAb, fixed HEp-2 cells were treated with either DNase, RNase, or
trypsin before staining with the mAb (Fig. 2). Fig. 2A illustrates the typical
nucleolar staining pattern ofthe HEp-2 cells without enzyme digestion. Pretreat-
ment of the cells with DNase failed to alter W8 binding to the nucleolus (Fig.
2B). However, pretreatment ofthe HEp-2 cells with RNase (Fig. 2C) or trypsin
(not shown) completely eliminated the immunofluorescent staining. As men-
ssDNA dsDNA RTE
W8 0.40 0.32 1.64
W99 0.32 0.07 0.07
W4 0.47 0.25 0.0
W20 1.29 0.86 0.0
W48 0.82 0.61 0.0
W64 0.56 0.44 0.0
W15 0.19 0.13 0.0
W76 0.09 0.09 0.0
0467.1 0.05 0.09 0.0
Culture medium 0.0 0.0 0.0CHIORAZZI AND REEVES
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FIGURE 2 .
￿
Indirect immunofluorescent staining of fixed HEp-2 cells using the W8 mAb . A,
staining performed on untreated HEp-2 cells ; B, staining performed after in situ DNase
treatment ofHEp-2 cells ; C, staining performed afterRNase treatment of HEp-2 cells. Original
magnification X 400 .
tioned above, the extractable nuclear antigens in the RTE preparation, with
which the patient's serum autoantibodies reacted, had been shown previously to
be RNase sensitive . As was the case for the W8 mAb, the nucleolar staining of
the serum autoantibodies similarly was found to disappear with RNase digestion
of the HEp-2 cells (not shown) .
Because the nucleolus is transcriptionally highly active, attempts were made to
determine if the antigen bound by W8 was involved in ribosomal RNA synthesis
and possibly associated with the transcriptional units of the ribosome . This was
evaluated by using the two antimetabolites, DRB and actinomycin D. DRB has
been shown to cause nucleolar dispersal or fragmentation while inhibiting mes-
senger but not ribosomal RNA transcription (31, 32) . Appropriate doses of
actinomycin D suppress ribosomal RNA synthesis without causing nucleolar
dispersal (33) .
When HEp-2 cells were incubated with DRB for 6 h and then stained with the
W8 mAb, the usual intact nucleolar pattern was replaced by a series of distinct
immunofluorescent dots (Fig . 3 B) . 2h of actinomycin D treatment resulted in a
more dense condensation of the nucleolus, without an alteration of immunoflu-
orescent staining (not shown) .
Studies by others (34) have demonstrated that antibodies to RNA polymerase
I stain the DRB-dispersed nucleolus in a pattern characteristic of the "necklaces"
seen when DRB induces unraveling of the nucleolus (31) . SinceRNA polymerase
I has been shown to be the target of autoantibodies in certain autoimmune
conditions (35), an experiment was performed to compare the immunofluores-
cent staining pattern of rabbit antibodies against RNA polymerase I (36) with
that of the human mAb W8 . This was done by indirect immunofluorescence
using a rhodamine-conjugated goat anti-rabbit antibody preparation and a
fluorescein-conjugated goat anti-human antibody preparation . As depicted in
Fig. 4, the rabbit antibodies to RNA polymerase I gave the typical, distinctive
necklace immunofluorescent configuration (Fig . 4A), whereas staining of the1178
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FIGURE 3 .
￿
Indirect immunofluorescent staining of fixed HEp-2 cells that were grown in
standard culturemedium (A) or in medium supplemented byDRB(25 ug/ml) for6h . Original
magnification x 400 .
same cell with theW8 mAb (Fig. 4B) yielded large dot-like staining that did not
appear to colocalize with thesmallerdots ofthe anti-RNA polymerase I necklace .
Comparison of the W8-extractable Nuclear Antigen with Other Known Autoanti-
gens . The antigenic specificity recognized by the W8 mAb was compared with
other previously defined reactivities in two ways . First, the extractable nuclear
antigens contained in the rabbit thymus extract were subfractionated by anion-
exchange chromatography and the fractions were reacted with the mAb or
control serum antibodies . Because the W8 mAb recognized an extractable
nuclear antigen, anti-Sm and anti-RNP autoantibodies, the first described ENA
systems (37, 38), were used as reference antibodies .
Fig. 5 illustrates the pattern of binding of (a) polyclonal anti-Sm or anti-RNP
reference antibodies, (b) the patient's serum and, (c) the W8 mAb to discrete
fractions of RTE that were isolated by gradient (50-500 mM) NaCl elution of
the RTE from a DE-52 column . As shown in Fig . 5A, anti-Sm antibodies bind
to multiple fractions of RTE eluted from the anion-exchange column ; these fall
into three broad peaks (1, 11, I11) . In contrast, anti-RNP antibodies bind only
those fractions in peak 11 . However, as illustrated in Fig. 5, B and C, the patient's
serum antibodies and the W8 mAb, respectively, do not show binding patterns
analogous to those observed with the anti-Sm or RNP reference autoantibodies.
Rather, these antibodies bind with increasing avidity to the more highly nega-
tively charged RTE protein fractions, suggesting that the patient's serum anti-
bodies and the W8 mAb are interacting with acidic residues which are capable
of binding relatively tightly to the anion exchanger, and which are distinct from
the Sm and RNP autoantigens .
A more direct comparison between the structure of theW8 antigen and other
known autoantigens was made by SDS-PAGE analysis of [s5S]methionine-labeled
cell extracts of K562 cells immunoprecipitated by either : (a) W8, (b) the mAb
from the parental fusion partner, 0467.3, (c) mAb W9 (another DNA-reactive
human mAb derived from the same fusion as W8), (d) normal human serum, (e)
the original patient's serum, and (f) serum from a patient with known anti-Sm
antibodies (Fig. 6) .
As shown previously (39), the anti-Sm serum (Fig . 6,Aand B) immunoprecip-
itated eight major bands with molecular masses ranging from 32 to 9 kD .CHIORAZZI AND REEVES
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FIGURE 4 . Comparison of indirect immunofluorescent staining patterns of HEp-2 cells
incubated with either rabbit anti-RNA polymerase I antibodies (A) or human mAb W8 (B) .
HEp-2 cells were grown for 48 h on glass coverslips, washed, and then cultured for another 6
h in DRB (25,ug/ml) . Rabbit antibodies to RNA polymerase I were incubated for 1 h, washed,
and then counterstained with rhodamine-conjugated goat anti-rabbit antibodies at 40 wg/ml ;
human mAb W8 was incubated with fixed HEp-2 cells overnight at 4°C and then counter-
stained with FITC-conjugated goat anti-human antibodies at 40 kg/ml . A and B represent the
same cell nucleus stained with these two antibody systems . Original magnification x 900 .
However, as shown, the W8 mAb immunoprecipitated two major bands with
molecular masses of 17 and 18 kD ; bands in the 32-50 kD range also were
identified, although theirappearance varied from experiment to experiment and
their significance is unclear at this time . Culture supernatant from the parental1180
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￿
Comparison of binding patterns of polyclonal anti-Sm and anti-RNP reference
antibodies (A), of the patient DW's serum (B), and the W8 mAb (C), to isolated fractions of
RTE. RTE fractions were prepared as described (25) by eluting the crude, bound antigens
from a DE-52 column with a 200 ml linear gradient of 50-500 mM NaCl in 10 mM sodium
phosphate(pH 7.5). 50-jut samples of individual fractions were then bound to enzyme immu-
noassay plate wellsandreacted with thevarious antibody preparations.Absorbance at 492nm
of each fraction is shown.
0467 .3 cell line and from the W9 culture (Fig. 6A) failed to immunoprecipitate
the 17 and 18 kD bands, even after prolonged autoradiographic exposure.
Fig. 6B demonstrates that the patient's serum antibodies immunoprecipitated
several proteins, including two proteins with molecular masses similar to those
immunoprecipitated by the W8 mAb (Fig. 6B, Pt serum), indicating that the
patient's serum autoantibodies and the mAb recognize the same proteins. In
other experiments, immunoprecipitation analyses of [s2P]orthophosphoric acid-
labeled cell extracts failed to demonstrate coprecipitation of labeled nucleolar
RNA species including U3, 8-2, and 7-2. RNAs (data not shown).
Discussion
A human B cell line (W8) was derived that secretes an IgM mAb reactive with
DNA and an ENA in enzyme immunoassay, and with nucleoli in a fluorescent
ANA assay. This multiple reactivity was a function of a single antibody from a
single immortalized B cell; prolonged culture and limiting-dilution cloning pro-
cedures failed to alter the data . The non-DNA antigenic moiety recognized by
the W8 mAb was expressed in the nucleolus of HEp-2 cells grown for 48 h in
vitro, and was sensitive to in situ enzymatic digestion with trypsin and RNase,
but not DNase (Fig. 2). In addition, this mAb bound to proteins that required a
high concentration of salt for displacement from a DEAE-cellulose column (Fig.
5), and therefore probably represent molecules with high concentrations ofCHIORAZZI AND REEVES
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FIGURE 6 . SDS-PAGE analyses of radiolabeled cellular proteins immunoprecipitated by
various antibody preparations. A (left to right) : 0467.3 culture supernatant, W9 mAb, W8
mAb, anti-Sm reference autoantibody containing serum . B, normal human serum, DW patient
serum, anti-Sm reference antibody serum .
negative charge . Several other autoantigens are known to be negatively charged,
either because of the presence of acidic residues on the protein moieties them-
selves or because of the intimate association of small RNA molecules with the
protein moieties (40, 41). However, attempts to determine if the latter is .the
case for the antigen recognized by the W8 mAb have been inconclusive (see
below) .
In addition, attempts were made to determine whether the nucleolar antigen
recognized by W8 was associated with the active transcriptional units of the
nucleolus . For these experiments, the halogenated ribofuranosylbenzimidazole,
DRB, was used to unravel the bound nucleolus into "nucleolar necklaces" (31),
which others have suggested correspond to linear arrays of active ribosomal
RNA genes and transcriptional units (34, 42) . In DRB-treated HEp-2 cells, the
W8 mAb appears to bind large dot-like fragments released from the nucleolus
(Fig . 3B) . However, it is unlikely that WS binds to intact RNA polymerase I or
to active transcriptional units, because the characteristic necklace configuration
of immunofluorescence seen with antibodies toRNA polymerase I (Fig. 4A) was
not visualized (Fig. 4B) in DRB-treated cells . This lack of colocalization ofRNA
polymerase I and W8 staining, after DRB treatment, is similar to that shown
previously (34) for the S1 antigen, a protein that is present in preribosomal
particles and is randomly distributed throughout the nucleus afterdrug exposure .
It is possible that the W8 antigen, like S1, is not an epitope of the transcriptional
machinery but of transcriptional products, which are dispersed separately into
the cell nucleus after DRB exposure (34) . In addition, treatment of the HEp-2
cells with actinomycin D resulted in further condensation of the nucleolus and1182
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persistent immunofluorescent staining with the W8 mAb, indicating that the
antigen is still expressed when ribosomal RNA synthesis is inhibited, a finding
that further distinguishes the antigen bound by W8 from RNA polymerase I.
Thus the W8 antigen appears to be a NaCl-extractable protein or ribonucleo-
protein with acidic domains that is localized primarily in the nucleolus of HEp-2
cells but is distinct from those antigens associated with the transcriptional units
of active ribosomal RNA genes.
Immunoprecipitation and SDS-PAGE analyses of [s5S]methionine-labeled cel-
lular proteins have provided preliminary information regarding the molecular
nature of the proteins bound by the W8 mAb. The W8 mAb immunoprecipitated
at least two polypeptides with molecular masses of 17 and 18 kD (Fig. 6). Higher
molecular mass bands ranging from ^-35 to 50 kD have appeared at times in W8
immunoprecipitates; the present studies cannot rule out the possibility that
certain of these proteins may be immunoprecipitated specifically or are coprecip-
itated by the W8 mAb. This is relevant because recent studies (43, 44) have
demonstrated that certain SLE sera contain autoantibodies to ribosomal proteins
of 38, 19, and 17 kD when analyzed by SDS-PAGE and western blotting of
isolated ribosomal proteins. These proteins (PO, P1, P2) appear to be analogous
to those described in lower eukaryotic species, yeast, and bacteria (45, 46), and
are acidic molecules that are part of a soluble protein-nucleic acid complex (44) .
Because the W8 antigen also is an RNase-sensitive, acidic protein composed of
at least two chains of 17 and 18 kD, the W8 and P systems may be related.
Although this possibility requires further evaluation, there is evidence that this
may not be the case. First, the W8 antigen is localized primarily to the nucleolus
in 48-h cultures of HEp-2 cells, whereas the P proteins are detected by SLE
serum antibodies primarily in the cytoplasm (44, 47-50). Second, the molecular
masses of these two sets of proteins, albeit similar, are not identical . In this
regard, it should be noted that a murine mAb, prepared against isolated nucleoli
and reactive with cytoplasmic P proteins, has reactivity with a nucleolar, mono-
meric (^"38 kD) form of the PI/P2 proteins (51). Finally, western blotting analysis
of the reactivity of the W8 mAb and the original patient's serum antibodies with
isolated ribosomal proteins failed to demonstrate reactivity of either set of
antibodies with the P proteins, although some reactivity of the patient's IgM
serumantibodies with other ribosomal proteins was noted (K. Elkon, unpublished
observations). Further studies will be necessary to determine if the W8 antigen
represents a distinct antigenic system or rather a nucleolar processing variant of
the cytoplasmic P proteins.
Whereas the initial characterization of the protein moieties recognized by the
W8 mAb has been helpful, attempts to define a s2P-labeled RNA species attached
to the W8 proteins have been unsuccessful to date. Although the bulk ofnucleolar
RNA is preribosomal and ribosomal RNA, certain small nuclear species, in
particular U3, 7-1, 7-2, and 8 S RNAs accumulate in the nucleolus in association
with pre-ribosomal RNA and ribosomal RNA. Previous studies have suggested
the existence of autoantibodies that coprecipitate U3 (37), or 7-2 and 8-2 (52,
53), nucleolar small RNAs. The protein moieties of these small nucleolar ribo-
nucleoproteins, which by analogy with other ANA systems are probably the
targets of the autoantibodies, have not been identified to date. However, it seemsCHIORAZZI AND REEVES
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unlikely that the antigen recognized by the W8 mAb is a component of these
three types of smaller nucleolar ribonucleoproteins because U3, 7-2, and 8-2 S
RNAs were not coprecipitated by the mAb or by the patient's serum, while in
the same experiment, reference antibodies to To/Th (52, 53) coprecipitated 7-
2 and 8-2 RNA (data not shown) . The reason(s) for these negative data are not
yet clear. One possibility is that the antigen recognized by the mAb binds to a
large RNA species (e.g ., rRNA precursor) that is not efficiently immunoprecipi-
tated, as has been noted in other systems (54) . A second possibility is that the
mAb recognizes a conformational determinant formed by protein and nucleic
acid moieties that are in close proximity within the nucleolus butnotpermanently
associated ; in such a situation the noncovalently linked complex might not
immunoprecipitate well . Finally, the affinity of the IgM W8 mAb may be
involved . In this regard, our studies (55) and those of others (14, 17) have shown
that human IgM mAb that react with DNA and other cellular constituents are
frequently of low antigen-binding activity and therefore may be difficult to use
for immunoprecipitation analyses. Studies to distinguish between these possibil-
ities are in progress .
The multiple antigenic reactivities of theW8 mAb arenotable . This IgM mAb
binds quite well to ssDNA and the nucleolarENA describedabove. The phenom-
enon of dual reactivity ofan mAb with DNA and other cellular structures has
been reported previously (55-58) . In humans, IgM mAb reactive with DNA
have been shown to also bind to and immunoprecipitate the intermediate
filament, vimentin (56) ; in mice, an mAb has been reported that is reactive with
DNA and Sm (58) . The frequency at which the W8 and other crossreactive
antibody specificities occur in the SLE population is unclear at this time . How-
ever, a retrospective review of SDS-PAGE analyses of labeled cellular proteins
immunoprecipitated by a panel ofSLE sera suggest that the W8 specificity is not
common .
Finally, if the W8 hybridoma cell is an immortalization of an autoantibody-
producing clone, as our data would suggest, then it is intriguing to postulate that
theapparently distinct serum autoantibody populations directed at ssDNA, ENA,
and nucleoli are actually the manifestation of the same antibody population that
is represented by the W8 mAb. This hypothesis is currently under investigation .
In any event, it is clear that human mAb obtained by immortalization of
autoreactive B cells are valuable probes for examining autoantigenic structures
shared by different molecules, such as nucleic acids and proteins . The multiple
reactivities displayed by the W8 and other such mAb might be illustrative of the
reactivities of other naturally occurring autoantibodies seen in normal and
diseased individuals.
Summary
B lymphocytes from a patient with systemic lupus erythematosus (SLE) and
several circulating autoantibodies (including antinucleolar antibodies) were im-
mortalized by fusion with a hypoxanthine/guanine phosphoribosyl transferase
(HGPRT)-deficient human B cell line . Multiple human monoclonal antibodies
(mAb) were obtained which, in solid-phase enzyme immunoassay, were reactive
with DNA. One mAb was of special interest because it reacted strongly with1184
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both single-stranded DNA and an extractable nuclear antigen found in rabbit
thymus extract (RTE). In an immunofluorescent assay using fixed human cells,
the latter mAb also bound predominantly to cell nucleoli. A combination of
enzyme digestion and metabolic inhibitor studies of the target cells in this
immunofluorescent assay suggested that the antigen(s) bound by the mAb was
an RNA-associated protein or a ribonucleoprotein that is distinct from intact
RNA polymerase I and not associated with the transcriptional units of the
nucleolus. In otherexperiments, using fractions ofRTE isolated by ion-exchange
chromatography, the antigens bound by the mAb were shown to be highly
negatively charged molecules. Immunoprecipitation and SDS-PAGE analyses of
labeled cell extracts bound by the mAb revealed a doublet of 17 and 18 kD.
Since the original patient's serum autoantibodies also bound toboth an RNase-
sensitive, acidic, extractable nuclear antigen and to nucleoli, and immunoprecip-
itated proteins of similar molecular masses in SDS-PAGE, it appears that the
described mAb is a product of an immortalized autoantibody-producing B cell
clone from the SLE patient's peripheral blood. This mAb probably defines a
novel RNA-associated autoantigen residing predominantly in the nucleolus or,
less likely, a variant of either RNA polymerase I or the ribosomal autoantigens
(P proteins).
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